510(k) K080911
K080911 is an FDA 510(k) premarket notification submitted by Bio-Rad Laboratories Inc., Clinical Systems Divisi for the device "VARIANT NBS SICKLE CELL PROGRAM REAGENT KIT, VARIANT NBS NEWBORN SCREENING SYSTEM AND VARIANT NBS WORKSTATION WITH". The FDA issued a decision of Substantially Equivalent on May 2, 2008. The device falls under product code GKA (Abnormal Hemoglobin Quantitation), a Class II device regulated under 21 CFR 864.7415. Bio-Rad Laboratories Inc., Clinical Systems Divisi has 2 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- May 2, 2008
- Date Received
- Apr 2, 2008
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Abnormal Hemoglobin Quantitation
- Device Class
- Class II
- Regulation Number
- 864.7415
- Review Panel
- HE
- Submission Type
- 510(k)
Need the full FDA record for Bio-Rad Laboratories Inc., Clinical Systems Divisi? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.